<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News Article and Medical Journal &#187; Dermatology</title>
	<atom:link href="http://d02now.com/category/dermatology/feed/" rel="self" type="application/rss+xml" />
	<link>http://d02now.com</link>
	<description></description>
	<lastBuildDate>Tue, 07 Dec 2010 17:40:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>2008 Psoriasis Journal: Biologic Therapies in the Treatment of Psoriatic Arthritis</title>
		<link>http://d02now.com/dermatology/2008-psoriasis-journal-biologic-therapies-in-the-treatment-of-psoriatic-arthritis.html</link>
		<comments>http://d02now.com/dermatology/2008-psoriasis-journal-biologic-therapies-in-the-treatment-of-psoriatic-arthritis.html#comments</comments>
		<pubDate>Fri, 06 Nov 2009 03:35:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[Psoriatic Arthritis]]></category>
		<category><![CDATA[Rheumatic]]></category>

		<guid isPermaLink="false">http://d02now.com/dermatology/2008-psoriasis-journal-biologic-therapies-in-the-treatment-of-psoriatic-arthritis.html</guid>
		<description><![CDATA[The following Journal will discuss the use of disease-mofifying antirheumatic drugs and the biologic-therapies in the treatment of moderate to severe psoriatic arthritis.]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/2008-psoriasis-journal-biologic-therapies-in-the-treatment-of-psoriatic-arthritis.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Relationship Between Atypical Moles and Melanoma</title>
		<link>http://d02now.com/dermatology/relationship-between-atypical-moles-and-melanoma.html</link>
		<comments>http://d02now.com/dermatology/relationship-between-atypical-moles-and-melanoma.html#comments</comments>
		<pubDate>Wed, 09 Sep 2009 16:04:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[atypical]]></category>
		<category><![CDATA[Melanoma]]></category>
		<category><![CDATA[mole]]></category>

		<guid isPermaLink="false">http://d02now.com/dermatology/relationship-between-atypical-moles-and-melanoma.html</guid>
		<description><![CDATA[This figure below shown the progressive development of an atypical mole into a superficial spreading melanoma. Like other moles, some may progress into melanoma but the majoity dissapear in time. An atypical mole if changing in size, shape or colour, it should be reviewed by a specialist]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/relationship-between-atypical-moles-and-melanoma.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>All About Scalp Psoriasis, Treatments and Tips Article</title>
		<link>http://d02now.com/dermatology/all-about-scalp-psoriasis-treatments-and-tips-article.html</link>
		<comments>http://d02now.com/dermatology/all-about-scalp-psoriasis-treatments-and-tips-article.html#comments</comments>
		<pubDate>Thu, 06 Aug 2009 16:03:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[dermatitis]]></category>
		<category><![CDATA[Scalp Psoriasis]]></category>
		<category><![CDATA[scalp psoriasis tips]]></category>
		<category><![CDATA[Scalp Treatment]]></category>

		<guid isPermaLink="false">http://d02now.com/dermatology/all-about-scalp-psoriasis-treatments-and-tips-article.html</guid>
		<description><![CDATA[How to treat scalp psoriasis, scalp treatments schedule, over the counter products commonly used to treat (salicyclic acid, medicated shampoo, tar), prescription products (anthralin, antimicrobial therapy, calcipotriene, calcipotriene and betamethasone dipropionate, intralesional steroid scalp injections, systemic treatments for psoriasis, tazarotene, topical steroids, ultraviolet light) are sections which well-described in this article.]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/all-about-scalp-psoriasis-treatments-and-tips-article.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Management</title>
		<link>http://d02now.com/dermatology/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management.html</link>
		<comments>http://d02now.com/dermatology/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management.html#comments</comments>
		<pubDate>Sat, 11 Jul 2009 07:10:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[control management]]></category>
		<category><![CDATA[Dermatology Journal]]></category>
		<category><![CDATA[management chart]]></category>
		<category><![CDATA[scoring system]]></category>
		<category><![CDATA[SCORTEN]]></category>
		<category><![CDATA[SJS]]></category>
		<category><![CDATA[SJS/TEN Diagnosis]]></category>
		<category><![CDATA[TEN]]></category>

		<guid isPermaLink="false">http://d02now.com/dermatology/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management.html</guid>
		<description><![CDATA[You will be provided with informations regarding the diagnosis and management of those two conditions. There are sections: recognising SJS and TEN, Managing Patients with SJS and TEN, Mimickers of SJS and TEN, the differences between erythema multiforme and SJS/TEN, Removal of cause (drugs related to SJS/TEN), Specific Treatment (Intravenous Immunoglobulin/IVIG, Systemic Corticosteroid, Cyclosporin A, Other Agents), Wound Care and Pain Control, Management of Fluid, Electrolyte, Respiration and Infection,  the complications of SJS/TEN and SCORTEN prognostic scoring system.]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Skin Protection Role in Cutaneous Melanoma Prevention</title>
		<link>http://d02now.com/dermatology/skin-protection-role-in-cutaneous-melanoma-prevention.html</link>
		<comments>http://d02now.com/dermatology/skin-protection-role-in-cutaneous-melanoma-prevention.html#comments</comments>
		<pubDate>Fri, 26 Jun 2009 04:05:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Melanoma Journal]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[Skin Protection]]></category>
		<category><![CDATA[SPF]]></category>
		<category><![CDATA[Sunscreen]]></category>
		<category><![CDATA[UV]]></category>

		<guid isPermaLink="false">http://d02now.com/dermatology/skin-protection-role-in-cutaneous-melanoma-prevention.html</guid>
		<description><![CDATA[Protection of the skin from a short, sharp burst of ultraviolet radiation seemed the most important role in preventing cutaneous melanomas such superficial spreading, lentigo maligna, nodular and acral lentiginous melanoma, according to a journal published in The PubMed Central Journal list. According to the journal, the use of adequate clothing particularly for high risk [...]]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/skin-protection-role-in-cutaneous-melanoma-prevention.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Treatment Guidelines of Psoriasis with Topical Medications</title>
		<link>http://d02now.com/dermatology/treatment-guidelines-of-psoriasis-with-topical-medications.html</link>
		<comments>http://d02now.com/dermatology/treatment-guidelines-of-psoriasis-with-topical-medications.html#comments</comments>
		<pubDate>Fri, 19 Jun 2009 23:44:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[Psoriasis Journal]]></category>
		<category><![CDATA[Psoriasis Treatment]]></category>
		<category><![CDATA[skin condition]]></category>
		<category><![CDATA[Topical]]></category>
		<category><![CDATA[Topical Agents]]></category>
		<category><![CDATA[Topical Medications]]></category>

		<guid isPermaLink="false">http://d02now.com/dermatology/treatment-guidelines-of-psoriasis-with-topical-medications.html</guid>
		<description><![CDATA[Below is a journal provide you treatment guidelines of psoriasis with topical agents such corticosteroids, vitamin D analogues, topical tazarotene, topical tacrolimus, pimecrolimus, emollients, salicylic acid, anthralin, coal tar and the combinations of those agents.]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/treatment-guidelines-of-psoriasis-with-topical-medications.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Melanoma in situ and Lentigo Maligna Qs &amp; As for Patients</title>
		<link>http://d02now.com/onkology/melanoma-in-situ-and-lentigo-maligna-qs-as-for-patients.html</link>
		<comments>http://d02now.com/onkology/melanoma-in-situ-and-lentigo-maligna-qs-as-for-patients.html#comments</comments>
		<pubDate>Fri, 29 May 2009 10:47:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Onkology]]></category>
		<category><![CDATA[In Situ]]></category>
		<category><![CDATA[lentigo maligna melanoma in situ]]></category>
		<category><![CDATA[Melanoma Leaflet]]></category>

		<guid isPermaLink="false">http://d02now.com/onkology/melanoma-in-situ-and-lentigo-maligna-qs-as-for-patients.html</guid>
		<description><![CDATA[Overall the article have description such as what melanoma in situ and lentigo maligna is, what does cancer in general mean, who gets melanoma, what causes melanoma in situ and lentigo maligna, what are the risk factors for developing melanoma in situ and lentigo maligna, how is melanoma in situ and lentigo melanoma diagnosed, how is melanoma in situ and lentigo melanoma treated, do we need any other treatment, will we be cured, and etc.]]></description>
		<wfw:commentRss>http://d02now.com/onkology/melanoma-in-situ-and-lentigo-maligna-qs-as-for-patients.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantificate Metallic Ingredients of Tattoo Pigment</title>
		<link>http://d02now.com/news/quantification-metallic-ingredients-of-tattoo-pigment.html</link>
		<comments>http://d02now.com/news/quantification-metallic-ingredients-of-tattoo-pigment.html#comments</comments>
		<pubDate>Sat, 04 Apr 2009 04:04:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Allergic Metals]]></category>
		<category><![CDATA[Tatoo inks]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/04/04/quantification-metallic-ingredients-of-tattoo-pigment/</guid>
		<description><![CDATA[Because it requires breaking the skin barrier, tattooing may carry health risks, including infection and allergic reactions as there were metal ingredients used in tattoo inks]]></description>
		<wfw:commentRss>http://d02now.com/news/quantification-metallic-ingredients-of-tattoo-pigment.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Melanoma of the Palms, Soles and Nail Bed: Acral Lentiginous Melanoma</title>
		<link>http://d02now.com/onkology/melanoma-of-the-palms-soles-and-nail-bed-acral-lentiginous-melanoma.html</link>
		<comments>http://d02now.com/onkology/melanoma-of-the-palms-soles-and-nail-bed-acral-lentiginous-melanoma.html#comments</comments>
		<pubDate>Tue, 31 Mar 2009 02:38:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Onkology]]></category>
		<category><![CDATA[Skin]]></category>
		<category><![CDATA[cutaneous malignant tumour]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/31/melanoma-of-the-palms-soles-and-nail-bed-acral-lentiginous-melanoma/</guid>
		<description><![CDATA[This sub-type of melanoma often occured on an area that seldom receives much sun exposure as this condition suggested that the aetiology is different from other sub-types of melanoma or that sun exposure is a lesser risk factor than another melanoma. It also has been suggested that Acral Lentiginous Melanoma itself carries a worse prognosis than other melanoma – often as lesions are recognised later than melanoma on other body sites.]]></description>
		<wfw:commentRss>http://d02now.com/onkology/melanoma-of-the-palms-soles-and-nail-bed-acral-lentiginous-melanoma.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acitretin for Nail Psoriasis Medication</title>
		<link>http://d02now.com/dermatology/acitretin-for-nail-psoriasis-medication.html</link>
		<comments>http://d02now.com/dermatology/acitretin-for-nail-psoriasis-medication.html#comments</comments>
		<pubDate>Thu, 26 Mar 2009 08:09:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Dermatology Journal]]></category>
		<category><![CDATA[Nail Psoriasis]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/26/acitretin-for-nail-psoriasis-medication/</guid>
		<description><![CDATA[Irregular pitting, salmon-colored patches on the nail bed, and onycholysis with erythematous borders, are commonly seen in fingernails. There could be any other abnormalities such splinter hemorrhages, nail-bed hyperkeratosis, nail thickening and crumbling, paronychia, and, rarely, leukonychia, erythema of the lunula, and trachyonychia.]]></description>
		<wfw:commentRss>http://d02now.com/dermatology/acitretin-for-nail-psoriasis-medication.html/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

